Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · Real-Time Price · USD

1.660

+0.050 (3.11%)

At close: Aug 21, 2026, 4:00 PM EDT

1.679

+0.019 (1.15%)

After-hours: Aug 21, 2026, 7:30 PM EDT

Caribou Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.19	12.36	16.29	51.16	58.34	240.42
Short-Term Investments	86.12	126.98	193.24	277.67	189.33	135.41
Cash & Short-Term Investments	112.31	139.34	209.54	328.83	247.66	375.83
Cash Growth	-38.94%	-33.50%	-36.28%	32.77%	-34.10%	2255.87%
Accounts Receivable	0.81	1.08	1.42	1.57	2.45	2.64
Other Receivables	1.14	1.9	1.83	2.29	2.22	5.48
Receivables	1.94	2.98	3.25	3.86	4.66	8.12
Prepaid Expenses	2.34	2.91	6.59	4.94	6.37	3.85
Other Current Assets	-	-	-	1.22	1.55	3.39
Total Current Assets	116.6	145.23	219.38	338.84	260.25	391.19
Property, Plant & Equipment	22.53	24.43	39.29	40.45	34.91	4.89
Long-Term Investments	1.5	3.51	49.13	51.33	77.07	45.3
Other Long-Term Assets	2.14	2.2	5.52	1.59	1.54	0.98
Total Assets	142.77	175.37	313.31	432.21	373.77	442.36

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.08	5.78	2.48	3.12	1.15	3.99
Accrued Expenses	11.45	15.72	21.94	19.65	14.41	12.09
Current Portion of Leases	1.38	1.2	1.43	1.2	0.97	-
Current Unearned Revenue	0.37	1.9	3.13	2.85	9.94	8.7
Other Current Liabilities	1.7	0.82	1.68	1.48	1.67	1.05
Total Current Liabilities	17.97	25.41	30.65	28.3	28.13	25.83
Long-Term Leases	25.28	26.03	25.06	25.91	26.78	-
Long-Term Unearned Revenue	1.42	1.75	3.32	6.1	15.95	22.03
Long-Term Deferred Tax Liabilities	-	-	0.55	0.56	0.38	0.48
Other Long-Term Liabilities	-	-	0.79	2.94	1.65	6.19
Total Liabilities	44.67	53.19	60.36	63.81	72.89	54.53

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	744.04	718.58	701.08	667.65	499.6	485.75
Retained Earnings	-645.88	-596.52	-448.39	-299.29	-197.22	-97.79
Comprehensive Income & Other	-0.07	0.1	0.26	0.03	-1.52	-0.14
Total Common Equity	98.1	122.18	252.95	368.4	300.87	387.83
Shareholders' Equity	98.1	122.18	252.95	368.4	300.87	387.83
Total Liabilities & Equity	142.77	175.37	313.31	432.21	373.77	442.36

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	26.66	27.23	26.49	27.11	27.75	-
Net Cash (Debt)	87.16	115.62	222.9	345.3	289.29	413.51
Net Cash Growth	-44.87%	-48.13%	-35.45%	19.36%	-30.04%	2796.73%
Net Cash Per Share	0.91	1.24	2.47	4.68	4.76	13.06
Filing Date Shares Outstanding	107.21	96.64	93	90.31	61.3	60.66
Total Common Shares Outstanding	106	95.14	92.38	88.45	61.03	60.26
Working Capital	98.62	119.82	188.73	310.54	232.12	365.36
Book Value Per Share	0.93	1.28	2.74	4.17	4.93	6.44
Tangible Book Value	98.1	122.18	252.95	368.4	300.87	387.83
Tangible Book Value Per Share	0.93	1.28	2.74	4.17	4.93	6.44
Machinery	17.24	17.23	20.65	16.98	13.46	7.25
Construction In Progress	-	-	-	8.2	0.99	0.01
Leasehold Improvements	3.06	3.06	11.52	2.24	1.88	1.7

SEC Filings: 10-K · 10-Q